Search research articles
Contact Us
Filters
Showing results (51-60 of 397) with videos related to
Page
of 40
Sort By:
Tropical Medicine and Health
|
December 8, 2017
Awareness of malaria and treatment-seeking behaviour among persons with acute undifferentiated fever in the endemic regions of Myanmar
Phyo Aung Naing, Thae Maung Maung, Jaya Prasad Tripathy, et al.
Cancer
|
January 24, 2009
Survival of patients in a Phase 1 Clinic: the M. D. Anderson Cancer Center experience
Jennifer Wheler, Apostolia M Tsimberidou, David Hong, et al.
Cureus
|
June 15, 2018
Staphylococcus Lugdunensis Endocarditis and Cerebrovascular Accident: A Systemic Review of Risk Factors and Clinical outcome
Htoo Kyaw, Felix Raju, Atif Z Shaikh, et al.
Oncology
|
December 17, 2013
Retreatment after secondary resistance or mixed response: a pilot study
Aung Naing, Rishi Agarwal, Gerald Falchook, et al.
Cureus
|
June 22, 2023
Ocular Toxicity Profile of Targeted Cancer Therapy (TCT) at a US Tertiary Cancer Center
Moe Ameri, Nagham Al Zubidi, Azadeh Razmandi, et al.
Journal for Immunotherapy of Cancer
|
December 14, 2020
Strategies for improving the management of immune-related adverse events
Aung Naing, Joud Hajjar, James L Gulley, et al.
Case Reports in Gastroenterology
|
June 22, 2018
Hypothermia-Related Acute Pancreatitis
Kyawzaw Lin, Emmanuel Ofori, Aung Naing Lin, et al.
Cancer Chemotherapy and Pharmacology
|
March 15, 2017
Phase I single dose, two-period and two-sequence cross-over trial to evaluate the relative bioavailability of two oral pimasertib formulations in advanced cancer patients
D Mahadevan, Monica Mita, Donald Richards, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 13, 2012
Change in tumor size by RECIST correlates linearly with overall survival in phase I oncology studies
Rajul K Jain, J Jack Lee, Chaan Ng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 11, 2010
Phase I oncology studies: evidence that in the era of targeted therapies patients on lower doses do not fare worse
Rajul K Jain, J Jack Lee, David Hong, et al.
Page
of 40
Search research articles
Search
Showing results (51-60 of 397) with videos related to
Sort By:
Page
of 40
Tropical Medicine and Health
|
December 8, 2017
Awareness of malaria and treatment-seeking behaviour among persons with acute undifferentiated fever in the endemic regions of Myanmar
Phyo Aung Naing, Thae Maung Maung, Jaya Prasad Tripathy, et al.
Cancer
|
January 24, 2009
Survival of patients in a Phase 1 Clinic: the M. D. Anderson Cancer Center experience
Jennifer Wheler, Apostolia M Tsimberidou, David Hong, et al.
Cureus
|
June 15, 2018
Staphylococcus Lugdunensis Endocarditis and Cerebrovascular Accident: A Systemic Review of Risk Factors and Clinical outcome
Htoo Kyaw, Felix Raju, Atif Z Shaikh, et al.
Oncology
|
December 17, 2013
Retreatment after secondary resistance or mixed response: a pilot study
Aung Naing, Rishi Agarwal, Gerald Falchook, et al.
Cureus
|
June 22, 2023
Ocular Toxicity Profile of Targeted Cancer Therapy (TCT) at a US Tertiary Cancer Center
Moe Ameri, Nagham Al Zubidi, Azadeh Razmandi, et al.
Journal for Immunotherapy of Cancer
|
December 14, 2020
Strategies for improving the management of immune-related adverse events
Aung Naing, Joud Hajjar, James L Gulley, et al.
Case Reports in Gastroenterology
|
June 22, 2018
Hypothermia-Related Acute Pancreatitis
Kyawzaw Lin, Emmanuel Ofori, Aung Naing Lin, et al.
Cancer Chemotherapy and Pharmacology
|
March 15, 2017
Phase I single dose, two-period and two-sequence cross-over trial to evaluate the relative bioavailability of two oral pimasertib formulations in advanced cancer patients
D Mahadevan, Monica Mita, Donald Richards, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 13, 2012
Change in tumor size by RECIST correlates linearly with overall survival in phase I oncology studies
Rajul K Jain, J Jack Lee, Chaan Ng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 11, 2010
Phase I oncology studies: evidence that in the era of targeted therapies patients on lower doses do not fare worse
Rajul K Jain, J Jack Lee, David Hong, et al.
Page
of 40